Pfizer Inc. buy Guggenheim
Start price
23.02.24
/
50%
€25.55
Target price
23.02.25
€33.22
Performance (%)
7.73%
Price
14:16
€27.14
Summary
This prediction is currently active. With a performance of 7.73%, the BUY prediction by Guggenheim for Pfizer Inc. is trending in the right direction. Dividends of €0.39 are taken into consideration when calculating the performance. This prediction currently runs until 23.02.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pfizer Inc. | 0.444% | 0.444% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for PFE provided by MarketBeat